RPTX Live signals | Maximize Profits with Getagraph.com

BUY 96498 min ago

@ $7.51

Issued: 13 Feb 2024 @ 09:30

Return: -58.06%

Previous signal: Feb 12 - 09:40

Previous signal: Sell

Return: -7.28 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States...

Stats
Today's Volume	219 182
Average Volume	130 517
Market Cap	132.87M
EPS	$0 ( 2024-02-27 )
Next earnings date	( $-0.100 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.410
ATR14	$0.0170 (0.54%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Segal Lloyd Mitchell	Sell	2 650	Common Shares
2024-04-01	Segal Lloyd Mitchell	Sell	2 491	Common Shares
2024-03-28	Forte Steve	Sell	825	Common Shares
2024-04-01	Forte Steve	Sell	789	Common Shares
2024-03-28	Zinda Michael	Sell	450	Common Shares

INSIDER POWER
67.70
Last 99 transactions
Buy: 4 214 315 \| Sell: 3 499 776

Volume Correlation

Long: -0.31 (neutral)

Short: -0.72 (moderate negative)

Signal:(43.067) Neutral

Repare Therapeutics Inc. Correlation

10 Most Positive Correlations
AYTU	0.905
RPRX	0.905
RMCF	0.901
ALRS	0.897
HFWA	0.896
LBPS	0.894
TRIT	0.894
AMRB	0.892
RBB	0.89
BMRA	0.886

10 Most Negative Correlations
DAKT	-0.913
CVT	-0.905
GBRG	-0.905
CMPO	-0.903
RAM	-0.899
DUOL	-0.897
VRIG	-0.894
BWMX	-0.893
BRACU	-0.882
HROW	-0.881

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Repare Therapeutics Inc. Correlation - Currency/Commodity

-0.33
( neutral )

-0.71
( moderate negative )

0.00
( neutral )

0.22
( neutral )

-0.76
( moderate negative )

-0.28
( neutral )

Repare Therapeutics Inc. Financials

Annual	2023
Revenue:	$51.13M
Gross Profit:	$49.18M (96.18 %)
EPS:	$-2.23

Q4	2023
Revenue:	$13.05M
Gross Profit:	$12.54M (96.12 %)
EPS:	$-0.670

Q3	2023
Revenue:	$2.16M
Gross Profit:	$1.11M (51.41 %)
EPS:	$-0.450

Q2	2023
Revenue:	$30.25M
Gross Profit:	$29.20M (96.53 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Repare Therapeutics Inc.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.